PTC Inc. operates as software company in the Americas, Europe, and the Asia Pacific. The company provides Windchill, a suite that manages all aspects of the product development lifecycle(PLM) that provides real-time information sharing, dynamic data visualization, collaborate across geographically distributed teams, and enabling manufacturers to elevate product development, manufacturing, field service, and end-of-life processes; ThingWorx, an Industrial Internet of Things software; ServiceMax, a service lifecycle management solutions enable companies to asset uptime with optimized in-person and remote service and technician productivity with mobile tools, and deliver metrics; and Arena, a SaaS PLM solution enables product teams to collaborate virtually to share product and quality information with internal teams and supply chain partners and deliver products to customers. It offers Codebeamer, an application lifecycle management for products and software development; Servigistics, a service parts management solution; and FlexPLM, a platform for merchandising and line planning, materials management, sampling, and others. In addition, it offers Kepware, an enterprise industrial connectivity solution; Creo, a 3D CAD technology enables the digital design, testing, and modification of product models; and Onshape, a SaaS product development platform that delivers computer-aided design with data management, collaboration tools, and real-time analytics. Further, it offers Vuforia, an augmented reality (AR) software; and Arbortext, a dynamic publishing solution streamlines how organizations create, manage, and publish technical documentation. PTC Inc. was incorporated in 1985 and is headquartered in Boston, Massachusetts.

PTC Inc.

The latest update is out from PTC Therapeutics ( ($PTCT) ). On June 18, 2026, PTC Therapeutics completed a private offering of $550 million of 0.0%...

PTC Therapeutics Completes Major Convertible Notes Offering

PTC Therapeutics ( ($PTCT) ) has provided an announcement. On June 8, 2026, PTC Therapeutics, Inc. announced that board member Alethia Young resign...

PTC Therapeutics Director Resigns, Moves to Advisory Role

An update from PTC Therapeutics ( ($PTCT) ) is now available. PTC Therapeutics reported the results of its June 2, 2026 annual meeting of stockhold...

PTC Therapeutics Shareholders Back Board, Pay and Auditor

In a report released today, Adam Borg from Stifel Nicolaus maintained a Buy rating on PTC, with a price target of $180.00. Borg covers the Technolo...

Stifel Nicolaus Remains a Buy on PTC (PTC)

Berenberg Bank analyst maintained a Hold rating on PTC yesterday and set a price target of $170.00. The company’s shares closed yesterday at $144.8...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PTC	$114.75	-1.87%	5.01M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	PTC	$114.75	-1.9%	5.01M
3
4
5
6

PTC

PTC

Get PTC Inc. Data in Excel

Get PTC Inc. Data in Excel